Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

108.97 -2.51 (-2.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biontech Se ADR

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
64 65 Next >
Thursday Predictions: 3 Hot Stocks for Tomorrow
Airline stocks, credit card stocks, and vaccine stocks are our focus when it comes to the hot stocks for tomorrow. Here's why. 
Via InvestorPlace
Analyst Ratings for BioNTech
Via Benzinga
COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today
The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19. 
Via Benzinga
Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20
Here's a round-up of stories from around the globe and from various media outlets. Benzinga 
Via Benzinga
Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots
Israel health ministry official said Isreal had not identified any evidence linking strokes to an updated coronavirus vaccine by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX). 
Via Benzinga
BioNTech Starts Dosing In Herpes Vaccine Candidate Study
Via Benzinga
Will Investors Notice Exciting Sign On BioNTech's Chart?
Via Benzinga
Pfizer (PFE) Stock Falls on Analyst Downgrade
Although Pfizer led the charge in forwarding Covid-19 solutions, possibly waning relevancy poses serious concerns for PFE stock. 
Via InvestorPlace
Pfizer Stock Dives As Analyst Calls For 'Covid Reset' And Downgrades Shares
Shares have skidded almost 10% in the first two weeks of 2023. 
Via Investor's Business Daily
US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People
The U.S. 
Via Benzinga
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand. 
Via Benzinga
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing”
Small-cap speculative biotech stocks regain interest with volatility. 
Via Talk Markets
BioNTech Strengthens Its Artificial Intelligence With Acquisition Of British Startup
Via Benzinga
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development
From BioNTech SE
Via GlobeNewswire
Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly
Israel based real-world study shows that omicron-targeted COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) reduced hospitalizations among older patients. 
Via Benzinga
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too. 
Via Investor's Business Daily
2 Top Biotech Stocks to Buy Right Now
These two pharmaceutical companies pay market-beating dividends to shareholders. 
Via The Motley Fool
BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030
From BioNTech SE
Via GlobeNewswire
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
Via Benzinga
Why BioNTech Was a Sickly Stock This Week
The world is trying hard to get past the coronavirus pandemic, and investors are trying hard to get past coronavirus stocks. 
Via The Motley Fool
BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference
From BioNTech SE
Via GlobeNewswire
Three Pharma Stocks to Sell Before They Die
As we head into New Year 2023, these are just some of the top pharma stocks to sell at the start of January. 
Via InvestorPlace
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
From BioNTech SE
Via GlobeNewswire
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
From BioNTech SE
Via GlobeNewswire
Update on First BioNTainer for African-based mRNA Manufacturing Facility
From BioNTech SE
Via GlobeNewswire
BioNTech Starts Phase 1 Clinical Trial for Prophylactic Herpes Simplex Virus-2 Vaccine Candidate BNT163
From BioNTech SE
Via GlobeNewswire
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
These seven hottest healthcare stocks have strong growth catalysts that could send each of them higher over the next few years. 
Via InvestorPlace
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
Moderna spiked on a cancer vaccine while Tesla continued to dive. 
Via Investor's Business Daily
BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
64 65 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.